RAPIDFACT Trademark

Trademark Overview

On Thursday, March 3, 2016, a trademark application was filed for RAPIDFACT with the United States Patent and Trademark Office. The USPTO has given the RAPIDFACT trademark a serial number of 79185521. The federal status of this trademark filing is SECTION 71 ACCEPTED as of Saturday, April 22, 2023. This trademark is owned by Quotient Clinical Ltd. The RAPIDFACT trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research services relating to the pharmaceutical, biotechnology and neutraceutical industry
rapidfact

General Information

Serial Number79185521
Word MarkRAPIDFACT
Filing DateThursday, March 3, 2016
Status706 - SECTION 71 ACCEPTED
Status DateSaturday, April 22, 2023
Registration Number5061646
Registration DateTuesday, October 18, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 2, 2016

Trademark Statements

Pseudo MarkRAPID FACT
Goods and ServicesResearch services relating to the pharmaceutical, biotechnology and neutraceutical industry

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, April 1, 2016
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameQuotient Sciences Limited
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressNOTTINGHAM NG11 6JS
GB
Party NameQuotient Clinical Ltd
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressGB
Party NameQuotient Clinical Ltd
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressGB

Trademark Events

Event DateEvent Description
Friday, March 15, 2024NEW REPRESENTATIVE AT IB RECEIVED
Saturday, April 22, 2023NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Saturday, April 22, 2023REGISTERED-SEC.71 ACCEPTED
Saturday, April 22, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Saturday, October 29, 2022CHANGE OF NAME/ADDRESS REC'D FROM IB
Monday, October 10, 2022TEAS SECTION 71 RECEIVED
Friday, March 10, 2017FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, February 23, 2017FINAL DISPOSITION NOTICE SENT TO IB
Thursday, February 23, 2017FINAL DISPOSITION PROCESSED
Wednesday, January 18, 2017FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, October 18, 2016REGISTERED-PRINCIPAL REGISTER
Friday, August 12, 2016NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Tuesday, August 2, 2016PUBLISHED FOR OPPOSITION
Wednesday, July 13, 2016NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, July 13, 2016NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, July 13, 2016NOTICE OF PUBLICATION
Saturday, July 9, 2016REFUSAL PROCESSED BY IB
Wednesday, June 29, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 28, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 28, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 28, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, June 20, 2016NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, June 20, 2016REFUSAL PROCESSED BY MPU
Saturday, June 18, 2016NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, June 17, 2016NON-FINAL ACTION WRITTEN
Thursday, June 16, 2016ASSIGNED TO EXAMINER
Tuesday, April 5, 2016APPLICATION FILING RECEIPT MAILED
Friday, April 1, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, March 31, 2016SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

rapidfact neutraceutical industry biotechnology pharmaceutical services relating research